/8-adrenergic receptor kinase (D6ARK) is a serine-threonine kinase involved in the process of homologous desensitization of G-coupled receptors. fARK is a member of a multigene family, consisting of six known subtypes, also named G protein-coupled receptor kinases (GRK 1-6). In this study we investigated the expression of GRKs during the process of T cell activation, which is of fundamental importance in regulating immune responses. T cell activation was induced by exposing mononuclear leukocytes (MNL) to PHA and confirmed by tritiated thymidine incorporation measurement. A substantial increase of GRK activity (as measured by in vitro phosphorylation of rhodopsin) was found after 48 h (331+80% of controls) and 72 h (347±86% of controls) of exposure to PHA. A threefold increase of /3ARK1 immunoreactivity was found in MNL exposed to PHA for 72 h. Persistent activation of protein kinase C (PKC) by 10 nM 12-O-tetradecanoylphorbol-13-acetate (TPA) was able to increase BARK activity to the same extent as PHA, suggesting a PKC-mediated mechanism. The kinetic of fl-adrenergic-stimulated cAMP production was substantially modified in TPA and PHA-activated cells, indicating that the increased GRK activity resulted in an increased fl-adrenergic homologous desensitization. A three-to fourfold increase in GRK activity was also observed in a population of T cell blasts (> 97% CD3+) exposed to PHA for 48-72 h. A significant increase in flARK1 and (3ARK2 mRNA expression was observed 48 h after mitogen stimulation, while mRNA expression of GRK5 and GRK6 was not changed. In conclusion our data show that the expression of GRK subtypes is actively and selectively modulated according to the functional state of T lymphocytes. (J. Clin. Invest. 1995. 95:203-210.)
Introduction
/3-adrenergic receptor kinase (,QARK)' is a serine-threonine kinase that is involved in the process of homologous desensitization of G protein-coupled receptors ( 1, 2) . Agonist occupancy triggers translocation of JARK from cytosol to plasma membranes, where it phosphorylates agonist-occupied receptors ( 1, 2) . ,/ARK-phosphorylated receptors are only minimally desensitized. An additional cytosolic protein, 3-arrestin, is required to induce maximal homologous desensitization (1) (2) (3) . ,/ARK may regulate a number of G-coupled receptors (1) (2) (3) (4) (5) , including 12-and a2-adrenergic receptors, muscarinic cholinergic receptors, somatostatin, platelet activating factor (PAF), PGEI as well as substance P receptors. Known substrate receptors are involved in functions as different as neurotransmission and regulation of immune responses through different intracellular second messengers (5) . P3ARK is a member of a multigene family, consisting of six known subtypes, which have also been named G protein coupled receptor kinases (GRK 1-6) due to the apparently unique functional association of such kinases with this receptor family (1, 4) . In this scheme rhodopsin kinase corresponds to GRK1, ,QARK1 to GRK2, and 13ARK2 to GRK3. While the expression of rhodopsin kinase is essentially confined to the retina, where it regulates phototransduction, a wide tissue distribution has been reported for many GRKs, the central nervous system being a site of relevant expression for most subtypes (1) (2) (3) . We have cloned the cDNAs of human ,3ARK1 (5) and J3ARK2 (6) , and demonstrated that PBL, and mononuclear leukocytes (MNL) in particular, represent a site of preferential expression for these kinases. High expression of GRK5 (Chuang and A. De Blasi, unpublished observation) and GRK6 (7) in PBL was also documented, while GRK4 was found not to be expressed in these cells (8) .
Several lines of evidence from our work suggested a functional role for ,BARK1 and possibly for other GRK subtypes, in MNL. We have shown that ,B-adrenergic receptor (P3AR) agonist isoproterenol and PAF can induce P3ARK translocation in these cells (5) . These agents are known to play important roles in modulating immune functions. We have also cloned the cDNA of human ,3-arrestinl (9) and shown that MNL express among the highest levels of /3-arrestinl. This adds further support to a functional role of the ,ARK/,/-arrestin mechanism of receptor desensitization in immune cells.
In this study we investigated the expression of GRKs during the process of T lymphocyte activation, which is of fundamental importance in regulating immune responses to foreign and self antigens. We found that the expression of GRK subtypes is actively and selectively modulated according to the functional state of T lymphocytes. In particular fARK1 and PARK2 expression was preferentially increased and seemed to be regulated through a protein kinase C (PKC)-mediated intracellular pathway.
Methods
Cell sources and treatments. MNL from healthy volunteers were fractionated using a Ficoll gradient as previously described (5) . 12-0-tetradecanoylphorbol-13-acetate (TPA) and ionomycin used for treatments were dissolved in DMSO (0.01% DMSO final concentration). T cell blasts were prepared as described by Rosoff and Mohan (10) .
Briefly, MNL were stimulated with S jsg/ml PHA and human recombinant interleukin 2 (HrIL-2, 10 U/ml) was added to the flasks on the third day. After 
Results
In vitro exposure of freshly isolated MNL to PHA is a well established procedure for T lymphocyte activation ( 14) . Various methods can be used to monitor this response. These include evaluation of the proliferative response of T lymphocytes by [3H]TdR incorporation, cell cycle DNA measurements, IL-2 secretion, and IL-2 receptor expression measurement (14) . To validate our model of T lymphocyte activation, the proliferative response of T cells upon exposure to PHA (5 pHg/ml) was monitored by [3H] TdR incorporation ( Fig. 1 a) . MNL stimulated with PHA for 4 or 24 h did not show significant incorporation as compared to the unstimulated controls (500-700 cpm, [3H]TdR incorporation was 20-30-fold higher than in controls 48 h after stimulation, and up to 60-fold higher 72 h after mitogen stimulation ( Fig. 1 a) . Unstimulated and PHAstimulated MNL were harvested in parallel at each time-point, and GRK activity was assayed on crude cytosolic preparations from these cells. Cytosolic kinase activity (per mg of protein) was unchanged 4 h after exposure to PHA (Fig. 1 b) , and slightly increased 24 h after stimulation (141±23% of controls, Fig. 1 b) . Substantial increases were observed after 48 h (331±80% of control) and 72 h (347±86% of controls) of exposure to PHA (Fig. 1, b and c) . In our experimental conditions the ROS phosphorylation assay was in the linear range and a similar increase in kinase activity was observed in PHAstimulated cells relative to untreated controls using amounts of cytosolic proteins ranging from 8 to 100 jsg per reaction. Some experiments using specific kinase inhibitors were performed to validate our phosphorylation assay. Heparin, which is known to selectively inhibit GRK phosphorylation activity both in vivo and in vitro (5) inhibited completely rhodopsin phosphorylation by cytosolic GRK preparations from either control or PHA-treated MNL. By contrast H7, a PKC inhibitor, did not affect rhodopsin phosphorylation at all (not shown). These results also rule out the possibility that the increase in ROS phosphorylation induced by PHA be due to a heparin- Two pathways of signaling play a major role in the process of T lymphocyte activation. These are represented by PKC and intracellular calcium (15, 16) . Both are activated after T cell receptor stimulation. It is well established that treatment of MNL with a combination of TPA and calcium ionophore can mimic receptor-mediated activation of T cells (15, 16) . To analyze the mechanisms of regulation of GRK activity, MNL were treated with a combination of 10 nM TPA, which induces persistent PKC activation in the absence of detectable downregulation of the kinase (15), and 0.5 pM ionomycin, which raises intracellular calcium. In our experiments, the proliferative response of MNL treated with TPA plus ionomycin was approximately of the same extent as that induced by PHA, as demonstrated by ['H] TdR incorporation (Fig. 3 a) . When given alone, TPA and ionomycin induced partial or negligible proliferative responses, respectively (Fig. 3 a) . After 72 h of treatment, GRK activity was increased by TPA plus ionomycin to the same level as by PHA (Fig. 3 b) . Ionomycin alone did not induce any change in GRK activity (Fig. 3 b) . By contrast TPA alone increased GRK activity to the same extent (three-to fourfold) as in fully activated MNL (i.e., treated either with PHA or with TPA plus ionomycin, Fig. 3 b) . After 72 h of treatment, TPA induced maximal increase of GRK activity while stimulating cell proliferation by only 50% (Fig. 3, a vs  b) . This indicated that GRK activity is increased in response to T cell activation rather than proliferation. This was even clearer when the kinase activity was measured after 48 h of treatment (Fig. 4) . Exposure to TPA for 48 h induced a maximal increase of GRK activity, whereas it did not stimulate any proliferative response (Fig. 4) , showing that GRK modulation can occur independently of cell proliferation.
Starting with the same number of cells we obtained different yields of cytosolic protein at the end of some treatments. In a typical experimental condition (n = 4), after 72 h of treatment one flask of MNL yielded 135±12 ug of cytosolic proteins from untreated cells, 233+±39 jig from PHA-treated (P < 0.05 vs control), 100±12 ig from TPA-treated, 125±9 ug from ionomycin-treated and 170+13 j.g from TPA + ionomycintreated cells. However, there was no correlation between the effects of treatment on GRK activity and the yield of proteins, as the same increase in kinase activity was found in MNL treated with PHA, TPA, and TPA + ionomycin (Fig. 3) , while protein yield from TPA-treated MNL was not significantly different from untreated cells.
The kinetic of cAMP accumulation in response to BAR agonist isoproterenol ( (Fig. 7) . Membrane-associated URK activity was the same in control and PHA-stimulated T cell blasts (Fig. 7) .
To investigate the possible changes of different GRK subtypes in mitogen-stimulated T lymphocytes, we studied the levels of mRNA expression of these kinases in T cell blasts stimulated with PHA for 48 h ( Fig. 8 and Table I Figure 7 . Increased GRK activity in mitogen-stimulated T cell blasts.
GRK activity was measured by ROS phosphorylation assays on T cell blasts untreated (control, C) or exposed to PHA for 48 h. Arrow indicates bands of phosphorylated rhodopsin (Opsin), as revealed by autoradiography after polyacrylamide gel electrophoresis. Cytosolic GRK preparations were assayed directly (Cytosol) or passed through a DEAE-Sephacel column, the eluate collected and measured for its rhodopsin-phosphorylating activity (post-DEAE cates that 63ARK1 is actively regulated in activated T cells.
,6ARK1 was indeed increased in PHA-activated MNL, as assessed by immunoblotting. The analysis of mRNA expression of different GRK subtypes further supported this possibility, as it showed a substantial and preferential increase of the expression of PARK1 in PHA-activated T cells. The expression of ,3ARK2 was also increased, but to a lower extent, while GRK5
and GRK6 were not affected by these treatments. These data strongly indicate a functional role of 3ARK in immune cells and describe a physiological process whereby /ARK expression is actively regulated. The activation of T lymphocytes is a pivotal event in the immune response of all vertebrates to foreign and self antigens ( 15, 16) . It is a multi-step phenomenon, triggered by effective contact of an external antigen with the antigen receptor TCR on the surface of a T lymphocyte. This activates a yet ill-defined cascade of signaling events, leading to persistent activation of PKC as well as to persistent rises of cytoplasmic calcium ( 15, 16) . Within a few hours following TCR stimulation, all of the early events determining the irreversible commitment of T lymphocytes to the activated state take place (16) . These include immediate induction of nuclear transcription factors as cfos, followed by increased levels of mRNA expression for IL-2, IL-2Ra, IL-4, IL-5, IFNy, and other lymphokines (16) . As a consequence of early events, expression of many relevant functional parameters is actively regulated at the molecular level in activated T lymphocytes. Our time-course experiments allocate the increase of,ARK activity among late GI-early S phase events following mitogen stimulation of T cells. At this stage, irreversible commitment of T lymphocytes to their activated state has already taken place (15, 16) . Increase of S3ARK expression appears then to be one of the phenotypic changes through which T cells adjust to suit their changed functional tasks. Increased expression of PKC subtypes has been demonstrated at the mRNA level in PHA-stimulated MNL, as well as in T cell blasts, with similar time-courses as for /ARK1 in our experiments (17, 18) . A similar profile of increase has been recently reported for a number of other kinase activities, regulated upon mitogenic stimulation of T lymphocytes (19) . A dramatic increase of PAF receptor has been demonstrated on the surface of T lymphocytes 48-72 h after stimulation with mitogen (20) . Higher levels of /3ARK may be related to higher levels of PAF receptors, for which a functional role of this kinase has already been suggested by our previous work (5) .
Although it is conceivable that several G-coupled receptors are functionally regulated by /ARK, evidence has accumulated showing that /ARK is directly involved in the mechanism of ,/-adrenergic receptor desensitization. Therefore, some experiments were done to assess whether homologous desensitization of /3AR is modified in TPA and PHA-stimulated MNL. It was found that the kinetic of cAMP production in response to isoproterenol was substantially modified in TPA and PHA-activated MNL; the production of cAMP was substantially reduced, while cAMP accumulation reached a plateau more rapidly than in control cells. These changes are indicative of increased homologous desensitization, consistent with the increased levels of GRK activity measured in these cells. Opposite changes (i.e., increased cAMP production and delayed attainment of maximal accumulation) were observed in cells in which /ARK-mediated desensitization was blunted, either by mutagenesis of the 63-adrenergic receptor or by a dominant negative 6ARK mutant (21, 22) . Other changes in the receptor-G protein cyclase system may occur in activated MNL which could, at least in part, modify the agonist-stimulated cAMP production. This is particularly true for PHA-treated cells where changes in shape, proliferative state, as well as in basal cAMP levels were observed (see Results and reference 23). However, as the kinetics of agonist-stimulated cAMP production were similarly modified in both TPA and PHA-activated MNL, these changes are likely to be due, at least in part, to an increased efficiency of homologous desensitization as a result of increased GRK activity.
An analysis of GRK subtypes based on sequence homology lead to the subdivision of this family into two subfamilies, with ,3ARK1 and /ARK2 representing one subfamily (1) . Our findings showing that ,6ARKI and ,/ARK2, but not GRK5 and GRK6, are increased in PHA-treated T cell indicate that one relatively homogeneous subgroup of GRK kinases is actively regulated during the process of T cell activation. A recent study reported that expression of 6LARK1, and to a lesser extent of ,/ARK2, was increased in the failing human heart (24) . It was suggested that this finding may explain, at least in part, the marked desensitization of the 6-adrenergic receptor system which has been documented to occur in such a pathological condition (24) .
Several lines of research have demonstrated that stimulation of PKC for at least 6 h is necessary for maximal T cell activation (15) . At that time the complex series of intracellular events that are initiated by PKC has been committed (15) . Our data clearly show that stimulation of PKC, as accomplished by exposing MNL to low doses of TPA, was able to induce an increase of /ARK comparable to that obtained by PHA treatment. These findings strongly indicate that the regulation of /6ARK expression is part of the cascade of events which is initiated by PKC activation. Persistent PKC activation has been shown to mediate a variety of events in the process of T lymphocyte activation (15) . Interestingly, PKC is directly responsible for the reduced responsiveness of activated T lymphocytes to further stimulation through TCR, by direct phosphorylation of TCR y subunits ( 15) . BARK modulation by a PKC-dependent mechanism may then represent another way through which responsiveness of T lymphocytes is tuned according to their functional state by PKC.
A different efficiency of mitogen-activated lymphocytes in desensitizing some type(s) of G-coupled receptor(s) is suggested by the evidence of decreased responsiveness to a variety of hormonal stimuli, including /-AR (Fig. 5) , PGE1, and histamine (23) . We propose that the increased /3ARK activity in activated T cells may represent one mechanism by which these cells can turn off some regulatory stimuli, possibly mediated through G-coupled receptors, which could interfere with their essential commitment to respond to a specific antigen.
In conclusion, we document the existence of an active mechanism of regulation for the expression of /lARK1 and, to a lesser extent, of /3ARK2. Our data clearly relate the increased expression of PARK to the process of T cell activation. These findings describe a new mechanism by which the regulation of receptor mediated responses can be modulated.
